FC Stock News
Friday, May 18, 2007
Medicare To Cut Reimbursement For Xopenex
Medicare reimbursements for Sepracor Inc.'s (SEPR) Xopenex will be slashed to the amount paid for a generic version of the asthma medication sending the stock price plunging $5.58 to close at $46.70.
posted by FC Market News at
9:50 AM
0 Comments:
Post a Comment
<< Home
About Me
Name:
FC Market News
View my complete profile
Previous Posts
Odyssey Marine Exploration Found Shipwreck
ValueClick Rises
Microsoft Offers $6 Billion For aQuantive
China Sunergy Surges In Market Debut
Alliance Data Systems Receives Buyout Offer
DUSA Receives Orphan Drug Status
Earnings Rise For J. C. Penney
Acxiom To Go Private
Doral Financial To Be Sold
Winn-Dixie Swings To Profit
0 Comments:
Post a Comment
<< Home